logo

For the Inventor, By the Inventor

Paris, France

Solange Chamaret

This inventor holds 26 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents, primarily in HIV Research. Top assignees: Institut Pasteur, The United States of America, as Represented by the Secretary, Department of Health and Human Services, Centre National De La Recherche Scientifique. Active years: 1987-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Solange Chamaret. Retrieved from https://idiyas.com/inventor/solange-chamaret

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 26

% Patents Active = 92.3



Average Co-Inventor Count = 10.1

ph-index = 7

Forward Citations = 258(Granted Patents)


Company Filing History:

goldMedal17 out of 898 
 
Institut Pasteur
 patents
silverMedal3 out of 3,697 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
bronzeMedal2 out of 5,383 
 
Centre National De La Recherche Scientifique
 patents
4. 2 out of 128 
 
Institut National De La Recherche Scientifique
 patents
5. 1 out of 1,853 
 
National Institute of Health and Medical Research
 patents
6. 1 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
7. 1 out of 2,202 
 
The United States of America as Represented by the Secretary of
 patents
8. 6 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1987-2008

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
HIV Antigen Compositions
Nucleic Acids
Antibodies
Diagnostic Methods
Viral Extracts
HIV Detection
Hybridomas
Peptides
In Vitro Diagnostics
Retrovirus
AIDS Detection
26 patents (USPTO):Explore Patents
1. 7341731 - HIV-2 antigen compositions (2008-03-11),
2. 7232654 - DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) (2007-06-19),
3. 7217508 - Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1) (2007-05-15),
4. 7205102 - Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA (2007-04-17),
5. 7122188 - Antibodies which bind with proteins of human immunodeficiency virus type 1 (HIV-1), and immune complexes comprising proteins of HIV-1 (2006-10-17),
6. 7115363 - Retrovirus capable of causing AIDS, means and methods for detecting it in vitro (2006-10-03),
7. 6664041 - Method for preparing a viral extract containing HIV-II RNA (2003-12-16),
8. 6627395 - Methods for the propagation, isolation, identification, and preparation of human immunodeficiency virus type 1 (HIV-1) (2003-09-30),
9. 6600023 - Antibody directed against HIV-1 P25 antigen (2003-07-29),
10. 6440657 - Nucleic acids and peptides of human immunodeficiency virus type (HIV-1) (2002-08-27),
11. 6428952 - Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies (2002-08-06),
12. 6395495 - Methods and kits for detecting antibodies against an HIV variant (2002-05-28),
13. 6322964 - Synthetic HIV-2 gag and env oligopeptides reactive with HIV-2 specific antibodies (2001-11-27),
14. 6265149 - In vitro diagnostic methods and kits for the detection of HIV-2-specific antibodies (2001-07-24),
15. 6037165 - Methods for the preparation of human immunodeficiency virus type 2 (2000-03-14),

Title: Innovations of Solange Chamaret in the Field of HIV Research

Introduction

Solange Chamaret is a distinguished inventor based in Paris, France, renowned for her significant contributions to the field of HIV research. With an impressive portfolio of 26 patents, her work reflects her commitment to understanding and combating the human immunodeficiency virus (HIV).

Latest Patents

Among her latest patents, the composition relating to HIV-2 antigens stands out. This invention involves a composition that includes at least one protein or glycoprotein of the HIV-2 virus, which is capable of infecting human T4 lymphocytes. Furthermore, the invention encompasses a process for producing these important retrovirus antigens by lysing cells infected with the virus or lysing purified virus, followed by the recovery of the antigens.

Another notable patent is the DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1). This invention aims to detect the presence of DNA, RNA, or antibodies associated with the lymphadenopathy retrovirus related to acquired immune deficiency syndrome. It also details the use of specific DNA fragments and vectors that include them, alongside the proteins that they express.

Career Highlights

Solange Chamaret has had a fruitful career, particularly in her role at Institut Pasteur. Her work at this prestigious research institution has enabled her to pave the way for innovations in HIV research, contributing vital knowledge to the scientific community and fostering advancements in medical science.

Collaborations

Throughout her career, Chamaret has collaborated with eminent scientists such as Luc Montagnier and Christine Rouzioux. These collaborations have not only enriched her research endeavors but have also led to groundbreaking findings that continue to impact the understanding and treatment of HIV.

Conclusion

In conclusion, Solange Chamaret's innovative work and patents underscore her vital role in the field of HIV research. Her dedication to developing effective solutions plays a crucial part in the ongoing fight against HIV, marking her as an influential inventor in the medical arena.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…